Global Marketing Strategy
Brazilian Aids manufacturers are not potential competitors at least in the short-run . However over the long-run , this is bound to change . Given their increased access to quality researchers , funding and know-how , it is only a matter of time before they also are able to create what drugs manufacturers currently singularly create . Within WTO provisions especially as concerns HIV /AIDS generic drugs in low purchasing power countries , there currently exists a provision relaxing patent law and allowing production of generics for the developing countries markets (World Trade Organization , 2003 . The generic manufacturers
are however strictly forbidden from competing against pharmaceutical companies in the high purchasing power markets with the cheap generics
Drugs can and should not be regarded as a standard marketable product They are not a luxury and sick people can not choose to do without them It should be noted that access to quality health should never be a negotiable point but rather a fundamental right . Manufacturers of drugs , have a responsibility to make sure drugs are available to patients at a reasonable price . For large pharmaceutical companies , the AIDS drugs should not be used as a profit generation item or vehicle Given the pandemic that has affected the world in relation to AIDS , this is not an issue of the manufacturers ' corporate social responsibility Rather , it must be moved and driven by corporations ' ethics . At the end of the day , the people who get saved by the antiretroviral drugs are future consumers of the manufacturers ' products . Additionally , when it comes to the survival of humanity , it should not be left to a company to decide whether or not to do something as is the case with social responsibility , rather is should be mandatory for the company to contribute fully to this effort
With the increased information...